New Zealand’s Pharmac Drug-Buying Agency Sets Two-Tiered Funding
This article was originally published in PharmAsia News
New Zealand’s drug-funding agency, Pharmac, has established a procedure for district health-board hospitals to standardize pharmaceutical treatments throughout the country.
You may also be interested in...
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.